Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

NCT00527514 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Amlodipine
DRUG: Olmesartan medoxomil plus amlodipine

Sponsor

Daiichi Sankyo